Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytek BioSciences

3.70
+0.05001.37%
Post-market: 3.700.00000.00%16:33 EDT
Volume:1.00M
Turnover:3.68M
Market Cap:473.96M
PE:-74.00
High:3.72
Open:3.58
Low:3.47
Close:3.65
Loading ...

Cytek Biosciences (CTKB) was downgraded to a Sell Rating at Goldman Sachs

TIPRANKS
·
31 Jan

Cytek Biosciences, Inc. (NASDAQ:CTKB) is largely controlled by institutional shareholders who own 53% of the company

Simply Wall St.
·
27 Jan

Institutional investors may adopt severe steps after Cytek Biosciences, Inc.'s (NASDAQ:CTKB) latest 24% drop adds to a year losses

Simply Wall St.
·
20 Jan

Cytek Biosciences Down Over 21%, on Pace for Largest Percent Decrease Since May 2023 -- Data Talk

Dow Jones
·
16 Jan

Cytek Biosciences Shares Fall On Low Preliminary 4Q Revenue

Dow Jones
·
15 Jan

Cytek Anticipates 2024 Revenue Between $200M-$201M, 4% Growth Over 2023; Q4 Revenue Expected At $57M-$58M, 11%-13% Rise from Q3 Amid $1.5M Impact from Stronger USD.

Benzinga
·
15 Jan

Cytek Biosciences Inc FY2024 REV View $204.7 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
15 Jan

Cytek Biosciences Inc - Expects 2024 Revenue Between $200 Million and $201 Million

THOMSON REUTERS
·
15 Jan

Morgan Stanley Sticks to Their Hold Rating for Cytek Biosciences (CTKB)

TIPRANKS
·
13 Jan

Crude Oil Gains 1%; Chicago PMI Falls In December

Benzinga
·
31 Dec 2024

Cytek Biosciences Launches $50 Million Share Buyback

MT Newswires Live
·
30 Dec 2024

Cytek Biosciences board approves $50M stock repurchase program

TIPRANKS
·
30 Dec 2024

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

THOMSON REUTERS
·
30 Dec 2024

Piper Sandler Sticks to Its Buy Rating for Cytek Biosciences (CTKB)

TIPRANKS
·
25 Nov 2024

Cytek Biosciences price target raised to $8.50 from $8 at Piper Sandler

TIPRANKS
·
11 Nov 2024

Stock Track | Cytek Biosciences Soars on Stellar Q3 2024 Results, Upbeat Outlook

Stock Track
·
07 Nov 2024

Cytek Biosciences Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
07 Nov 2024

Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views

Benzinga
·
07 Nov 2024

Stock Track | Cytek Biosciences Soars Over 33% on Q3 Beat and Raised Guidance

Stock Track
·
06 Nov 2024

Stock Track | Cytek Biosciences Soars 7% Pre-Market on Upbeat Q3 Results, Raised Guidance

Stock Track
·
06 Nov 2024